Commentary

Video

Dr Kutikov on Therapeutic Approaches in Urothelial Cancer Requiring Cystectomy

Author(s):

Alexander Kutikov, MD, FACS
Conference|American Urological Association Annual Meeting

Alexander Kutikov, MD, FACS, discusses treatment options for patients with urothelial cancer requiring cystectomy.

Alexander Kutikov, MD, FACS, chair and professor, Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, discusses treatment options for patients with urothelial cancer requiring cystectomy.

Related Videos
Rohan Garje, MD
John K. Lee, MD, PhD, associate professor-in-residence, Division of Hematology/Oncology, Department of Medicine; the Institute for Urologic Oncology, Department of Urology, the David Geffen School of Medicine, UCLA Heath
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Related Content
Yash Chhabra, PhD
January 23rd 2025

Fox Chase Cancer Center Scientist Yash Chhabra Honored With NextGen Stars Award From American Association for Cancer Research

Oncology Unplugged
August 7th 2024

Park and Grivas Expand on Treatment Updates in Bladder Cancer

Urothelial Carcinoma | Image Credit: © Sebastian Kaulitzki- stock.adobe.com
January 22nd 2025

UGN-102 Shows Favorable Risk-Benefit Profile, Sustained CR Rates in Low-Grade, Intermediate-Risk NMIBC

Oncology Unplugged
July 24th 2024

Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer

Cancer | Image Credit: © catalin - stock.adobe.com
January 21st 2025

Fox Chase Cancer Center’s Roland Dunbrack Appointed Co-Leader of the Cancer Signaling and Microenvironment Program

Qing Chen, MD, PhD
January 17th 2025

Fox Chase Cancer Center Welcomes Dr. Qing Chen